Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry

Find Full text
Thumbnail
Fulltext:
233486.pdf
Embargo:
until further notice
Size:
443.9Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2021
Author(s)
Ariens, Lieneke F.M.
Schaft, Jorien van der
Spekhorst, L.S.
Bakker, Daphne S.
Romeijn, G.L.E.
Kouwenhoven, T.A.
Kamsteeg, M.
Schuttelaar, Marie L.A.
Bruin-Weller, Marjolein S. de
Source
Journal of the American Academy of Dermatology, 84, 4, (2021), pp. 1000-1009
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/233486   https://hdl.handle.net/2066/233486
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.